SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.55-5.5%Jan 5 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Turbo Lawyer who wrote (3882)9/24/1997 1:31:00 AM
From: aknahow   of 17367
 
Turbo, nice post. Investors Business Daily shows 16 fund holding XOMA thats indicated as an increase. Up from 14 if I remember correctly but could have been up from 12. So in part some of buying over past months came from funds.

When I mention CBMI on this thread it is in large part because I think XOMA can and should copy or exceed CBMI performance. CBMI does absolutly nothing about keeping anyone informed. Sturza's person mentioned how inept they are in this area. And yet value seems to be perceived in any event. Imagine Xoma if and when it finally has some good news. There are several events that can propel Xoma. Iprex deal, Neuprex deal, Trauma Trial info, Meningococcemia trial new or halt, CF trials, and licensing deals.

So even if there is no halt and no immediate go ahead to use Neuprex for meningococcemia I think it still represents an interestg situation. Thats why I bought more at $8 1/8. BTW its obvious I have a investment in this stock and that does unfortunatly tend to bias my opinion. I want Xoma to succeed. But I hope that my wishes are not the faer to all my thoughts on XOMA.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext